Only line in the announcement potentially relating to potency assays is the last bit in my opinion - "...seeking to address all remaining product characterization issues".
Potency assay stuff is product characterization stuff - so that could be an acknowledgement (in an obscure general way - that they don't have an all clear on potency assay approach) but as I said "product characterization" is a broader term. It could pick up screening product for viral contamination etc and a bunch of other stuff unrelated to potency assays (as specific metrics intended to track product potency).
- Forums
- ASX - By Stock
- Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
Only line in the announcement potentially relating to potency...
- There are more pages in this discussion • 568 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.07 |
Change
-0.060(5.33%) |
Mkt cap ! $1.275B |
Open | High | Low | Value | Volume |
$1.14 | $1.14 | $1.07 | $5.556M | 5.065M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 193123 | $1.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.07 | 300057 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 224786 | 1.060 |
11 | 397783 | 1.055 |
20 | 157278 | 1.050 |
3 | 33950 | 1.045 |
6 | 109389 | 1.040 |
Price($) | Vol. | No. |
---|---|---|
1.065 | 13563 | 1 |
1.070 | 346403 | 4 |
1.075 | 10000 | 1 |
1.080 | 31739 | 2 |
1.085 | 100209 | 3 |
Last trade - 16.10pm 05/06/2024 (20 minute delay) ? |
|
|||||
Last
$1.07 |
  |
Change
-0.060 ( 5.22 %) |
|||
Open | High | Low | Volume | ||
$1.13 | $1.14 | $1.07 | 1328053 | ||
Last updated 15.59pm 05/06/2024 ? |
Featured News
MSB (ASX) Chart |
The Watchlist
MGU
MAGNUM MINING AND EXPLORATION LIMITED
Neil Goodman, MD
Neil Goodman
MD
Previous Video
Next Video
SPONSORED BY The Market Online